認知症専門医のための臨床神経病理学

出版社： ワールドプランニング
著者：
発行日： 2019-05-30
分野： 臨床医学：内科  >  脳神経科学/神経内科学
ISBN： 9784863511507
電子書籍版： 2019-05-30 （第1版第2刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

3,080 円(税込)

購入する
電子書籍
章別単位で購入
ブラウザ、アプリ閲覧

2,156 円(税込)

購入する

商品紹介

認知症の専門医が知らなければならない脳病理とはどのようなものなのか…？
臨床能力を高めるためにあなたは何をしなければならないのか？
目前に悩む患者が求めるものは何なのか？
臨床の現場では、日々の診断に迷い、いつも治療に新たな課題が突き付けられています。

目次

  • 第I部　臨床神経病理学と脳病理解剖の基本
    　第1章　臨床精神医学と臨床精神病理学
    　第2章　脳病理解剖

    第II部　老年期の精神科臨床で遭遇する疾患と臨床神経病理
    　第1章　アルツハイマー病
    　第2章　レビー小体病
    　第3章　前頭側頭葉変性症（1）
    　第4章　前頭側頭葉変性症（2）
    　第5章　タウオパチー（1）
    　第6章　タウオパチー（2）
    　第7章　ハンチントン病
    　第8章　アルコール性脳障害の背景病理
    　第9章　クロイツフェルト・ヤコブ病
    　第10章　脳血管障害の病理

    第III部　認知症外来における神経病理学的アプローチ
    　第1章　臨床精神医学と臨床神経病理の接点（1）
    　第2章　臨床精神医学と臨床神経病理の接点（2）
    　第3章　神経画像はどこまで神経病理像を反映させうるか

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

第I部 臨床神経病理学と脳病理解剖の基本

P.13 掲載の参考文献
1) Alzheimer A : Uber eigenartige Krankheitsfalle des spateren Alters. Zeitschrift fur die Gesamte Neurologie und Psychiatrie, 4 : 356-385 (1911).
 
2) Brain Bank (神経疾患ブレインバンク) ホームページ : http://www.brain-bank.org
 
3) Clinton WJ : Remarks at the White House Conference on Mental Health. The American Presidency Project, June 7, 1999. Available at : http://www.presidency.ucsb.edu/ws/?pid=576914) Galimberti D, Dell'Osso B, Altamura AC, Scarpini E : Psychiatric symptoms in frontotemporal dementia ; Epidemiology, phenotypes, and differential diagnosis. Biol Psychiatry, 78 (10) : 684-692 (2015).
 
5) Griesinger W : Die Pathologie und Therapie der psychischen Krankheiten, fur Aerzte und Studierende. 1, Verlag von Adolph Krabbe, Stuttgart (1845).
 
6) Harrison PJ : The neuropathology of schizophre nia ; A critical review of the data and their interpretation. Brain, 122 (Pt 4) : 593-624 (1999).
 
7) Hippius H, Moller H-J, Neundorfer-Kohl G : The University Department of Psychiatry in Munich ; From Kraepelin and His Predecessors to Molecular Psychiatry. 32, Springer, Heidelberg (2008).
 
8) 萬年甫 : 脳を固める・切る・染める ; 先人の知恵. メディカルレビュー社, 東京 (2011).
 
9) Marneros A : Psychiatry's 200th birthday. Br J Psychiatry, 193 (1) : 1-3 (2008).
 
10) Miyakawa T, Sumiyoshi S, Deshimaru M, Suzuki T, et al. : Electron microscopic study on schizophrenia ; Mechanism of pathological changes. Acta Neuropathol, 20 (1) : 67-77 (1972).
PubMed
11) Murray RM : Neurodevelopmental schizophrenia ; The rediscovery of dementia praecox. Br J Psychiatry Suppl, (25) : 6-12 (1994).
PubMed
12) Muller U, Winter P, Graeber MB : A presenilin 1 mutation in the first case of Alzheimer's disease. Lancet Neurol, 12 (2) : 129-130 (2013).
PubMed
13) 下田光造 : 精神分裂病の病理解剖 (第11回日本医学会総会演説記録). 精神経誌, 46 (9) : 557-572 (1942).
 
14) Stachowiak MK, Kucinski A, Curl R, Syposs C, et al. : Schizophrenia ; A neurodevelopmental disorder-Integrative genomic hypothesis and therapeutic implications from a transgenic mouse model. Schizophr Res, 143 (2-3) : 367-376 (2013).
 
15) Szasz TS : The Manufacture of Madness ; A Comparative Study of the Inquisition and the Mental Health Movement. 15-16, Syracuse U.P., New York (1997).
 
16) Szasz TS : Coercion as Cure ; A Critical History of Psychiatry. 117, Transaction Publishers, New Brunswick (NJ, USA), London (2010).
 
17) Tatetsu S : On histologie findings in schizophrenia and schizophrenic state. In Biological Mechanisms of Schizophrenia and Schizophrenia-like Psychoses, ed. by Mitsuda H, Fukuda T, 288-289, Igaku-Shoin, Tokyo (1974).
 
18) Velakoulis D, Walterfang M, Mocellin R, Pantelis C, et al. : Frontotemporal dementia presenting as schizophrenia-like psychosis in young people ; Clinicopathological series and review of cases. Br J Psychiatry, 194 (4) : 298-305 (2009)
PubMed

第II部 老年期の精神科臨床で遭遇する疾患と臨床神経病理

P.38 掲載の参考文献
1) Alzheimer A : Uber einen eigenartigen schweren Erkrankungsprozes der Hirnrinde. Neurologisches Centralblatt, 23 : 1129-1136 (1906).
 
2) Alzheimer A : Uber eigenartige Krankheitsfalle des spateren Alters. Zeitschrift fur die Gesamte Neurologie und Psychiatrie, 4 : 356-385 (1911).
 
3) Arendt T : Synaptic plasticity and cell cycle activation in neurons are alternative effector pathways ; The 'Dr. Jekyll and Mr. Hyde concept' of Alzheimer's disease or the yin and yang of neuroplasticity. Prog Neurobiol, 71 (2-3) : 83-248 (2003).
 
4) Braak H, Braak E : Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol, 82 (4) : 239-259 (1991).
PubMed
5) Braak H, Braak E : Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol Aging, 16 (3) : 271-278 (1995).
PubMed
6) Braak H, Braak E : Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis. Acta Neuropathol, 92 (2) : 197-201 (1996).
PubMed
7) Douaud G, Groves AR, Tamnes CK, Westlye LT, et al. : A common brain network links development, aging, and vulnerability to disease. Proc Natl Acad Sci U S A, 111 (49) : 17648-17653 (2014).
PubMed
8) Gomez-Isla T, Hollister R, West H, Mui S, et al. : Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann Neurol, 41 (1) : 17-24 (1997).
PubMed
9) Hyman BT, Phelps CH, Beach TG, Bigio EH, et al. : National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimers Dement, 8 (1) : 1-13 (2012).
PubMed
10) 池田研二 : 脳病理解剖 ; 脳のマクロ所見からわかること, ミクロ所見からわかること. 老年精神医学雑誌, 28 (5) : 529-539 (2017).
Medical*Online
11) 池田研二 : アルツハイマー型認知症 (Alzheimer-type dementia : ATD) の病理. 日本認知症学会公式サイト, Available at : http://dementia.umin.jp/link4-1.html
 
12) 猪瀬正 : Alzheimer, Alois臨床神経病理学の創始者. (松下正明編) 精神医学を築いた人々・上巻, 177-192, ワールドプランニング, 東京 (1991).
 
13) 入谷修司 : 臨床精神医学と臨床神経病理学. 老年精神医学雑誌, 28 (4) : 391-400 (2017).
Medical*Online
14) Jellinger KA, Stadelmann C : Problems of cell death in neurodegeneration and Alzheimer's Disease. J Alzheimers Dis, 3 (1) : 31-40 (2001).
 
15) Kanazawa I : How do neurons die in neurodegenerative diseases? Trends Mol Med, 7 (8) : 339-344 (2001).
PubMed
16) Khachaturian ZS : Diagnosis of Alzheimer's disease. Arch Neurol, 42 (11) : 1097-1105 (1985).
 
17) Maurer K, Volk S, Gerbaldo H : Auguste D and Alzheimer's disease. Lancet, 349 (9064) : 1546-1549 (1997).
 
18) Mirra SS, Heyman A, McKeel D, Sumi SM, et al. : The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) ; Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology, 41 (4) : 479-486 (1991).
 
19) 宮川太平 : アルツハイマー病脳に見られる構造病変. 蛋白質 核酸 酵素, 43 (7) : 875-878 (1998).
Medical*Online
20) Muller U, Winter P, Graeber MB : A presenilin 1 mutation in the first case of Alzheimer's disease. Lancet Neurol, 12 (2) : 129-130 (2013).
PubMed
21) 村山繁雄, 齊藤祐子 : アルツハイマー病の病理. 医学のあゆみ, 257 (5) : 533-541 (2016).
Medical*Online
22) Newell KL, Hyman BT, Growdon JH, Hedley-Whyte ET : Application of the National Institute on Aging (NIA) -Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease. J Neuropathol Exp Neurol, 58 (11) : 1147-1155 (1999).
PubMed
23) Nunomura A, Castellani RJ, Lee HG, Moreira PI, et al. : Neuropathology in Alzheimer's disease ; Awaking from a hundred-year-old dream. Sci Aging Knowledge Environ, 2006 (8) : pe10 (2006).
 
24) 布村明彦 : アルツハイマー病における神経精神症状の神経病理学的基盤. 老年精神医学雑誌, 27 (1) : 18-26 (2016).
Medical*Online
25) Perry G, Nunomura A, Smith MA : A suicide note from Alzheimer disease neurons? Nat Med, 4 (8) : 897-898 (1998).
PubMed
26) Rupp C, Beyreuther K, Maurer K, Kins S : A presenilin 1 mutation in the first case of Alzheimer's disease ; Revisited. Alzheimers Dement, 10 (6) : 869-872 (2014).
PubMed
27) Selkoe DJ : Alzheimer's disease is a synaptic failure. Science, 298 (5594) : 789-791 (2002).
PubMed
28) Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT : Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med, 1 (1) : a006189 (2011).
 
29) Terry RD, Masliah E, Salmon DP, Butters N, et al. : Physical basis of cognitive alterations in Alzheimer's disease ; Synapse loss is the major correlate of cognitive impairment. Ann Neurol, 30 (4) : 572-580 (1991).
PubMed
30) Thal DR, Rub U, Orantes M, Braak H : Phases of Aβ-deposition in the human brain and its relevance for the development of AD. Neurology, 58 (12) : 1791-1800 (2002).
 
31) The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease : Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol Aging, 18〔4 Suppl.〕 : S1-2 (1997).
 
32) 吉岡愛智郎 : ALOIS ALZHEIMERについて. 神経研究の進歩, 9 (3) : 592-609 (1965).
 
P.48 掲載の参考文献
1) Abdelnour C, van Steenoven I, Londos E, Blanc F, et al. : Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia. Mov Disord, 31 (8) : 1203-1208 (2016).
PubMed
2) Adler CH, Dugger BN, Hentz JG, Hinni ML, et al. : Peripheral synucleinopathy in early Parkinson's disease ; Submandibular gland needle biopsy findings. Neurology, 82 (10) : 858-864 (2014).
 
3) Antelmi E, Donadio V, Incensi A, Plazzi G, et al. : Skin nerve phosphorylated α-Synuclein deposits in idiopathic REM sleep behavior disorder. Neurology, 88 (22) : 1-4 (2017).
 
4) Berg D, Postuma RB, Adler CH, Bloem BR, et al. : MDS Research criteria for prodromal Parkinson's disease. Mov Disord, 30 (12) : 1600-1609 (2015).
PubMed
5) Braak H, Del Tredici K, Rub U, de Vos RA, et al. : Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging, 24 (2) : 197-211 (2003).
PubMed
6) Dickson DW, Ruan D, Crystal H, Mark MH, et al. : Hippocampal degeneration differences diffuse Lewy body disease (DLBD) from Alzheimer's disease ; Light and electron microscopic immunohistochemistry of CA2-3 neurites specific to DLBD. Neurology, 41 (9) : 1402-1409 (1990).
 
7) Dickson DW, Fujishiro H, Delledonne A, Menke J, et al. : Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease. Acta Neuropathol, 115 (4) : 437-444 (2008).
PubMed
8) Dickson DW, Braak H, Duda JE, Duyckaerts C, et al. : Neuropathological assessment of Parkinson's disease ; Refining the diagnostic criteria. Lancet Neurol, 8 (12) : 1150-1157 (2009).
PubMed
9) Doppler K, Jentschke H-M, Schulmeyer L, Vadasz D, et al. : Dermal phosphor-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease. Acta Neuropathol, 133 (4) : 535-545 (2017).
 
10) Fearnley JM, Lees AJ : Ageing and Parkinson's disease ; Substantia nigra regional selectivity. Brain, 114 (Pt 5) : 2283-2301 (1991).
PubMed
11) Fujimi K, Sasaki K, Noda K, Wakisaka Y, et al. : Clinicopathological outline of dementia with Lewy bodies applying the revised criteria ; The Hisayama study. Brain Pathol, 18 (3) : 317-325 (2008).
PubMed
12) Fujishiro H, Ferman TJ, Boeve BF, Smith GE, et al. : Validation of the neuropathologic criteria of the third consortium for dementia with Lewy bodies for prospectively diagnosed cases. J Neuropathol Exp Neurol, 67 (7) : 649-656 (2008).
 
13) Fujishiro H, Nakamura S, Sato K, Iseki E : Prodromal dementia with Lewy bodies. Geriatr Gerontol Int, 15 (7) : 817-826 (2015).
PubMed
14) 藤城弘樹 : レビー小体型認知症の前駆状態. 精神医学, 157 (10) : 811-818 (2015).
 
15) Gelb DJ, Oliver E, Gilman S : Diagnostic criteria for Parkinson disease. Arch Neurol, 56 (1) : 33-39 (1999).
PubMed
16) Greffard S, Verny M, Bonnet AM, Beinis JY, et al. : Motor score of the unified Parkinson disease rating scale as a good predictor of Lewy body-associated neuronal loss in the substantia nigra. Arch Neurol, 63 (4) : 584-588 (2006).
PubMed
17) Halliday GM, McCann H : The progression of pathology in Parkinson's disease. Ann N Y Acad Sci, 1184 : 188-195 (2010).
PubMed
18) Halliday GM, Holton JL, Revesz T, Dickson DW : Neuropathology underlying clinical variability in patients with synucleiopathies. Acta Neuropathol, 122 (2) : 187-204 (2011).
 
19) Hansen L, Salmon D, Galasko D, Masliah E, et al. : The Lewy body variant of Alzheimer's disease ; A clinical and pathologic entity. Neurology, 40 (1) : 1-8 (1990).
PubMed
20) Hyman BT, Phelps CH, Beach TG, Bigio EH, et al. : National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimers Dement, 8 (1) : 1-13 (2012).
PubMed
21) 井関栄三 : レビー小体型認知症 ; 臨床と病理. 中外医学社, 東京 (2014).
 
22) 小阪憲司, 松下正明, 小柳新策, Mehraein P : "Lewy小体病"の臨床神経病理学的研究. 精神経誌, 82 (5) : 292-311 (1980).
 
23) Kosaka K : Diffuse Lewy body disease in Japan. J Neurol, 237 (3) : 197-204 (1990).
PubMed
24) McKeith IG, Galasko D, Kosaka K, Perry EK, et al. : Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies. Neurology, 47 (5) : 1113-1124 (1996).
PubMed
25) McKeith IG, Dickson DW, Lowe J, Emre M, et al. ; Consortium on DLB : Diagnosis and management of dementia with Lewy bodies ; Third report of the DLB Consortium. Neurology, 65 (12) 1863-1872 (2005).
 
26) McKeith IG, Boeve BF, Dickson DW, Halliday G, et al. : Diagnosis and management of dementia with Lewy bodies ; Fourth consensus report of the DLB Consortium. Neurology, 89 (1) : 88-100 (2017).
PubMed
27) Minguez-Castellanos A, Chamorro CE, Escamilla-Sevilla F, Ortega-Moreno A, et al. : Do alpha-synuclein aggregates in autonomic plexuses predate Lewy body disorders? ; A cohort study. Neurology, 68 (23) : 2012-2018 (2007).
PubMed
28) Postuma RB, Berg D, Stern M, Poewe W, et al. : MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord, 30 (12) : 1591-1601 (2015).
PubMed
29) Sarro L, Senjem ML, Lundt ES, Przybelski SA, et al. : Amyloid-β deposition and regional grey matter atrophy rates in dementia with Lewy bodies. Brain, 139 (Pt 10) : 2740-2750 (2016).
 
30) Shannon KM, Keshavarzian A, Mutlu E, Dodiya HB, et al. : Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease. Mov Disord, 27 (6) : 709-715 (2012).
PubMed
31) Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, et al. : Alpha-synuclein in Lewy bodies. Nature, 388 (6645) : 839-840 (1997).
PubMed
32) Sunwoo MK, Hong JY, Choi J, Park HJ, et al. : α-Synuclein pathology is related to postoperative delirium in patients undergoing gastrectomy. Neurology, 80 (9) : 810-813 (2013).
 
33) Tsopelas C, Stewart R, Savva GM, Brayne C, et al. : Neuropathological correlates of late-life depression in older people. Br J Psychiatry, 198 (2) : 109-114 (2011).
PubMed
34) Vingerhoets FJ, Schulzer M, Calne DB, Snow BJ : Which clinical sign of Parkinson's disease best reflects the nigrostriatal lesion? Ann Neurol, 41 (1) : 58-64 (1997).
PubMed
P.62 掲載の参考文献
1) 新井哲明, 山下万貴子, 細川雅人, 野中隆ほか : 前頭側頭葉変性症の分子病理. Dementia Japan, 25 (2) : 120-128 (2011).
 
2) 有馬邦正, 小柳新策, 小阪憲司, 松下正明 : Pick病における嗜銀球の脳内分布について. 精神経誌, 89 (1) : 43-72 (1987).
 
3) Boeve BF : Links between frontotemporal lobar degeneration, corticobasal degeneration, progressive supranuclear palsy, and amyotrophic lateral sclerosis. Alzheimer Dis Assoc Disord, 21 (4) : S31-38 (2007).
PubMed
4) Dickson DW : Pick's disease ; A modern approach. Brain Pathol, 8 (2) : 339-354 (1998).
PubMed
5) Ferrer I, Lopez-Gonzalez I, Carmona M, Arregui L, et al. : Glial and neuronal tau pathology in tauopathies ; Characterization of disease-specific phenotypes and tau pathology progression. J Neuropathol Exp Neurol, 73 (1) : 81-97 (2014).
PubMed
6) Geser F, Martinez-Lage M, Robinson J, Uryu K, et al. : Clinical and pathological continuum of multisystem TDP-43 proteinopathies. Arch Neurol, 66 (2) : 180-189 (2009).
PubMed
7) Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, et al. : Classification of primary progressive aphasia and its variants. Neurology, 76 (11) : 1006-1014 (2011).
PubMed
8) Ikeda K : Neuropathological discrepancy between Japanese Pick's disease without Pick bodies and frontal lobe degeneration type of frontotemporal dementia proposed by Lund and Manchester Group. Neuropathology, 20 (1) : 76-82 (2000).
PubMed
9) 池田研二 : Motor neuron disease inclusion dementia (MNDID) の神経病理. 神経研究の進歩, 48 (3) : 369-376 (2004).
 
10) 池本明人 : FTDP-17の神経病理. 神経研究の進歩, 48 (3) : 429-440 (2004).
 
11) Irwin DJ, Brettschneider J, McMillan CT, Cooper F, et al. : Deep clinical and neuropathological phenotyping of Pick disease. Ann Neurol, 79 (2) : 272-287 (2016).
PubMed
12) Josephs KA, Hodges JR, Snowden JS, Mackenzie IR, et al. : Neuropathological background of phenotypical variability in frontotemporal dementia. Acta Neuropathol, 122 (2) : 137-153 (2011).
PubMed
13) 川勝忍 : II. 老化と脳 D. 画像. (本間昭, 武田雅俊編) 臨床精神医学講座・第12巻 ; 老年期精神障害, 77-84, 中山書店, 東京 (1998).
 
14) 川勝忍, 渋谷譲, 山崎猛, 渡部俊幸ほか : 画像と病理診断を踏まえた認知症の鑑別診断. 老年精神医学雑誌, 22 (増刊-I) : 28-35 (2011).
 
15) 川勝忍, 小林良太, 林博史 : 運動ニューロン疾患を伴う前頭側頭型認知症 (湯浅・三山病) の病態と診断. 精神医学, 57 (10) : 849-856 (2015).
 
16) 小阪憲司 : Pick病 ; 日本における報告例を中心として. 臨床精神医学, 11 (6) : 693-703 (1982).
 
17) Mackenzie IR, Neumann M, Baborie A, Sampathu DM, et al. : A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol, 122 (1) : 111-113 (2011).
PubMed
18) Majounie E, Renton AE, Mok K, Dopper EG, et al. : Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia ; Cross-sectional study. Lancet Neurol, 11 (4) : 323-330 (2012).
PubMed
19) 尾籠晃司, 飯田仁志 : 前頭側頭葉変性症の鑑別診断. 最新医学, 68 (4) : 810-819 (2013).
Medical*Online
20) Probst A, Tolnay M, Langui D, Goedert M, et al. : Pick's disease ; Hyperphosphorylated tau protein segregates to the somatoaxonal compartment. Acta Neuropathol, 92 (6) : 588-596 (1996).
 
21) 土谷邦秋 : Pick病の歴史と概念の変遷. 神経内科, 50 (4) : 321-328 (1999).
 
22) 横田修, 土谷邦秋 : Pick病の臨床と病理. 臨床神経学, 49 (5) : 235-248 (2009).
 
23) 横田修, 土谷邦秋 : Pick病の病理. Clinical Neuroscience, 27 (3) : 320-324 (2009).
 
24) 横田修, 土谷邦秋, 寺田整司, 石津秀樹ほか : Pick病と前頭側頭葉変性症 ; 臨床病理研究の新しい時代. 精神医学, 52 (8) : 738-754 (2010).
 
P.70 掲載の参考文献
1) Arai T, Hasegawa M, Akiyama H, Ikeda K, et al. : TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun, 351 (3) : 602-611 (2006).
PubMed
2) Arai T : Significance and limitation of the pathological classification of TDP-43 proteinopathy. Neuropathology, 34 (6) : 578-588 (2014).
PubMed
3) Brettschneider J, Del Tredici K, Toledo JB, Robinson JL, et al. : Stages of pTDP-43 pathology in amyotrophic lateral sclerosis. Ann Neurol, 74 (1) : 20-38 (2013).
PubMed
4) F. グレイ, U. デ・ジロラーミ, J. ポワリエ (村山繁雄監訳) : エスクロール基本神経病理学. 初版, 167-169, 西村書店, 東京 (2009).
 
5) Hasegawa M, Arai T, Nonaka T, Kametani F, et al. : Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann Neurol, 64 (1) : 60-70 (2008).
PubMed
6) Hasegawa M, Nonaka T, Tsuji H, Tamaoka A, et al. : Molecular dissection of TDP-43 proteinopathies. J Mol Neurosci, 45 (3) : 480-485 (2011).
PubMed
7) Karageorgiou E, Miller BL : Frontotemporal lobar degeneration ; A clinical approach. Semin Neurol, 34 (2) : 189-201 (2014).
PubMed
8) Kwiatkowski TJ Jr, Bosco DA, Leclerc AL, Tamrazian E, et al. : Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science, 323 (5918) : 1205-1208 (2009).
PubMed
9) Mackenzie IR, Neumann M, Baborie A, Sampathu DM, et al. : A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol, 122 (1) : 111-113 (2011).
PubMed
10) Mackenzie IR, Neumann M : Molecular neuropathology of frontotemporal dementia ; Insights into disease mechanisms from postmortem studies. J Neurochem, 138 〔Suppl.1〕 : 54-70 (2016).
PubMed
11) Munoz DG, Neumann M, Kusaka H, Yokota O, et al. : FUS pathology in basophilic inclusion body disease. Acta Neuropathol, 118 (5) : 617-627 (2009).
PubMed
12) Neumann M, Sampathu DM, Kwong LK, Micsenyi MC, et al. : Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science, 314 (5796) : 130-133 (2006).
PubMed
13) Neumann M, Rademakers R, Roeber S, Baker M, et al. : A new subtype of frontotemporal lobar degeneration with FUS pathology. Brain, 132 (Pt 11) : 2922-2931 (2009).
 
14) Neumann M, Roeber S, Kretzschmar HA, Rademakers R, et al. : Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion disease. Acta Neuropathol, 118 (5) : 605-616 (2009).
PubMed
15) Onari K, Spatz H : Anatomische Beitrage zur Lehre von Pickschen umschriebenen Groβhirnrinden Atrophie (Picksche Krankheit). Z Ges Neurol Psychiatr, 101 : 470-511 (1926).
 
16) Pick A : Ueber die Beziehungen der senilen Hirnatrophie zur Aphasie. Prag Med Wochenschr, 17 : 165-167 (1892).
 
17) Strong MJ, Abrahams S, Goldstein LH, Woolley S, et al. : Amyotrophic lateral sclerosis-frontotemporal spectrum disorder (ALS-FTSD) ; Revised diagnostic criteria. Amyotrophic Lateral Scler Frontotemporal Degener, 18 (3-4) : 153-174 (2017).
 
18) Tollervey JR, Curk T, Rogelj B, Briese M, et al. : Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nat Neurosci, 14 (4) : 452-458 (2011).
PubMed
19) Turner MR : Motor neuron disease ; Biomarker development for an expanding cerebral syndrome. Clin Med (Lond), 16〔Suppl.6〕 : 60-65 (2016).
 
P.85 掲載の参考文献
1) Aarsland D, Litvan I, Larsen JP : Neuropsychiatric symptoms of patients with progressive supranuclear palsy and Parkinson's disease. J Neuropsychiatry Clin Neurosci, 13 (1) : 42-49 (2001).
PubMed
2) 天野直二 : 進行性核上性麻痺. (松下正明総編集, 浅井昌弘, 牛島定信, 倉知正佳, 小山司ほか編) 臨床精神医学講座・第10巻 ; 器質・症状性精神障害, 160-176, 中山書店, 東京 (1997).
 
3) Arai T, Ikeda K, Akiyama H, Shikamoto Y, et al. : Distinct isoforms of tau aggregated in neurons and glial cells in brains of patients with Pick's disease, corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathol, 101 (2) : 167-173 (2001).
PubMed
4) Arai T, Ikeda K, Akiyama H, Nonaka T, et al. : Identification of amino-terminally cleaved tau fragments that distinguish progressive supranuclear palsy from corticobasal degeneration. Ann Neurol, 55 (1) : 72-79 (2004).
PubMed
5) Armstrong MJ, Litvan I, Lang AE, Bak TH, et al. : Criteria for the diagnosis of corticobasal degeneration. Neurology, 80 (5) : 496-503 (2013).
 
6) Bergeron C, Pollanen MS, Weyer L, Black SE, et al. : Unusual clinical presentations of cortical-basal ganglionic degeneration. Ann Neurol, 40 (6) : 893-900 (1996).
PubMed
7) Braak H, Braak E : Argyrophilic grains ; Characteristic pathology of cerebral cortex in cases of adult onset dementia without Alzheimer changes. Neurosci Lett, 76 (1) : 124-127 (1987).
PubMed
8) Dickson DW, Bergeron C, Chin SS, Duyckaerts C, et al. : Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol, 61 (11) : 935-946 (2002).
PubMed
9) Dickson DW, Ahmed Z, Algom AA, Tsuboi Y, et al. : Neuropathology of variants of progressive supranuclear palsy. Curr Opin Neurol, 23 (4) : 394-400 (2010).
PubMed
10) Dickson DW, Hauw JJ, Agid Y, Litvan I : Progressive supranuclear palsy and corticobasal degeneration. In Neurodegeneration ; The Molecular Pathology of Dementia and Movement Disorders, 2nd ed., ed. by Dickson DW, Weller RO, 135-155, Wiley-Blackwell Press, UK (2011).
 
11) Dugger BN, Adler CH, Shill HA, Caviness J, et al. ; Arizona Parkinson's Disease Consortium : Concomitant pathologies among a spectrum of parkinsonian disorders. Parkinsonism Relat Disord, 20 (5) : 525-529 (2014).
PubMed
12) Geda YE, Boeve BF, Negash S, Graff-Radford NR, et al. : Neuropsychiatric features in 36 pathologically confirmed cases of corticobasal degeneration. J Neuropsychiatry Clin Neurosci, 19 (1) : 77-80 (2007).
 
13) Hassan A, Whitwell JL, Boeve BF, Jack CR Jr, et al. : Symmetric corticobasal degeneration (S-CBD). Parkinsonism Relat Disord, 16 (3) : 208-214 (2010).
PubMed
14) Hassan A, Parisi JE, Josephs KA : Autopsy-proven progressive supranuclear palsy presenting as behavioral variant frontotemporal dementia. Neurocase, 18 (6) : 478-488 (2012).
PubMed
15) Hattori M, Hashizume Y, Yoshida M, Iwasaki Y, et al. : Distribution of astrocytic plaques in the corticobasal degeneration brain and comparison with tuft-shaped astrocytes in the progressive supranuclear palsy brain. Acta Neuropathol, 106 (2) : 143-149 (2003).
PubMed
16) Hauw JJ, Daniel SE, Dickson D, Horoupian DS, et al. : Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology, 44 (11) : 2015-2019 (1994).
PubMed
17) Hoglinger GU, Respondek G, Stamelou M, Kurz C, et al. : Clinical diagnosis of progressive supranuclear palsy ; The movement disorder society criteria. Mov Disord, 32 (6) : 853-864 (2017).
PubMed
18) Ikeda C, Yokota O, Nagao S, Ishizu H, et al. : Corticobasal degeneration initially developing motor versus non-motor symptoms ; A comparative clinicopathological study. PSYCHOGERIATRICS, 14 (3) : 152-164 (2014).
PubMed
19) Ikeda C, Yokota O, Nagao S, Ishizu H, et al. : The relationship between development of neuronal and astrocytic tau pathologies in subcortical nuclei and progression of argyrophilic grain disease. Brain Pathol, 26 (4) : 488-505 (2016).
PubMed
20) Ikeda K, Akiyama H, Iritani S, Kase K, et al. : Corticobasal degeneration with primary progressive aphasia and accentuated cortical lesion in superior temporal gyrus ; Case report and review. Acta Neuropathol, 92 (5) : 534-539 (1996).
PubMed
21) Iwasaki Y, Yoshida M, Hattori M, Goto A, et al. : Distribution of tuft-shaped astrocytes in the cerebral cortex in progressive supranuclear palsy. Acta Neuropathol, 108 (5) : 399-405 (2004).
PubMed
22) Iwasaki Y, Mori K, Ito M, Tatsumi S, et al. : An autopsied case of progressive supranuclear palsy presenting with cerebellar ataxia and severe cerebellar involvement. Neuropathology, 33 (5) : 561-567 (2013).
PubMed
23) Josephs KA, Duffy JR, Strand EA, Whitwell JL, et al. : Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. Brain, 129 (Pt 6) : 1385-1398 (2006).
PubMed
24) Josephs KA, Katsuse O, Beccano-Kelly DA, Lin WL, et al. : Atypical progressive supranuclear palsy with corticospinal tract degeneration. J Neuropathol Exp Neurol, 65 (4) : 396-405 (2006).
PubMed
25) Josephs KA, Petersen RC, Knopman DS, Boeve BF, et al. : Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology, 66 (1) : 41-48 (2006).
PubMed
26) Katsuse O, Iseki E, Arai T, Akiyama H, et al. : 4-repeat tauopathy sharing pathological and biochemical features of corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathol, 106 (3) : 251-260 (2003).
PubMed
27) Kertesz A, McMonagle P, Blair M, Davidson W, et al. : The evolution and pathology of frontotemporal dementia. Brain, 128 (Pt 9) : 1996-2005 (2005).
PubMed
28) Koga S, Sanchez-Contreras M, Josephs KA, Uitti RJ, et al. : Distribution and characteristics of transactive response DNA binding protein 43 kDa pathology in progressive supranuclear palsy. Mov Disord, 32 (2) : 246-255 (2017).
PubMed
29) Koga S, Kouri N, Walton RL, Ebbert MTW, et al. : Corticobasal degeneration with TDP-43 pathology presenting with progressive supranuclear palsy syndrome ; A distinct clinicopathologic subtype. Acta Neuropathol, 136 (3) : 389-404 (2018).
PubMed
30) Komori T, Arai N, Oda M, Nakayama H, et al. : Astrocytic plaques and tufts of abnormal fibers do not coexist in corticobasal degeneration and progressive supranuclear palsy. Acta Neuropathol, 96 (4) : 401-408 (1998).
 
31) Kouri N, Murray ME, Hassan A, Rademakers R, et al. : Neuropathological features of corticobasal degeneration presenting as corticobasal syndrome or Richardson syndrome. Brain, 134 (Pt 11) : 3264-3275 (2011).
PubMed
32) Lee SE, Rabinovici GD, Mayo MC, Wilson SM, et al. : Clinicopathological correlations in corticobasal degeneration. Ann Neurol, 70 (2) : 327-340 (2011).
PubMed
33) Ling H, O'Sullivan SS, Holton JL, Revesz T, et al. : Does corticobasal degeneration exist? ; A clinicopathological re-evaluation. Brain, 133 (Pt 7) : 2045-2057 (2010).
 
34) Ling H, de Silva R, Massey LA, Courtney R, et al. : Characteristics of progressive supranuclear palsy presenting with corticobasal syndrome ; A cortical variant. Neuropathol Appl Neurobiol, 40 (2) : 149-163 (2014).
PubMed
35) Ling H, Kovacs GG, Vonsattel JP, Davey K, et al. : Astrogliopathy predominates the earliest stage of corticobasal degeneration pathology. Brain, 139 (Pt 12) : 3237-3252 (2016).
PubMed
36) Litvan I, Mega MS, Cummings JL, Fairbanks L : Neuropsychiatric aspects of progressive supranuclear palsy. Neurology, 47 (5) : 1184-1189 (1996).
PubMed
37) Litvan I, Cummings JL, Mega M : Neuropsychiatric features of corticobasal degeneration. J Neurol Neurosurg Psychiatry, 65 (5) : 717-721 (1998).
PubMed
38) Mathew R, Bak TH, Hodges JR : Diagnostic criteria for corticobasal syndrome ; A comparative study. J Neurol Neurosurg Psychiatry, 83 (4) : 405-410 (2012).
PubMed
39) Mimura M, Oda T, Tsuchiya K, Kato M, et al. : Corticobasal degeneration presenting with nonfluent primary progressive aphasia ; A clinicopathological study. J Neurol Sci, 183 (1) : 19-26 (2001).
 
40) Muller J, Seppi K, Stefanova N, Poewe W, et al. : Freezing of gait in postmortem-confirmed atypical parkinsonism. Mov Disord, 17 (5) : 1041-1045 (2002).
PubMed
41) Nagao S, Yokota O, Nanba R, Takata H, et al. : Progressive supranuclear palsy presenting as primary lateral sclerosis but lacking parkinsonism, gaze palsy, aphasia, or dementia. J Neurol Sci, 323 (1-2) : 147-153 (2012).
PubMed
42) Nagao S, Yokota O, Ikeda C, Takeda N, et al. : Argyrophilic grain disease as a neurodegenerative substrate in late-onset schizophrenia and delusional disorders. Eur Arch Psychiatry Clin Neurosci, 264 (4) : 317-331 (2014).
PubMed
43) Oide T, Ohara S, Yazawa M, Inoue K, et al. : Progressive supranuclear palsy with asymmetric tau pathology presenting with unilateral limb dystonia. Acta Neuropathol, 104 (2) : 209-214 (2002).
PubMed
44) Rebeiz JJ, Kolodny EH, Richardson EP Jr : Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol, 18 (1) : 20-33 (1968).
PubMed
45) Respondek G, Stamelou M, Kurz C, Ferguson LW, et al. : The phenotypic spectrum of progressive supranuclear palsy ; A retrospective multicenter study of 100 definite cases. Mov Disord, 29 (14) : 1758-1766 (2014).
PubMed
46) Snowden JS, Thompson JC, Stopford CL, Richardson AM, et al. : The clinical diagnosis of early-onset dementias ; Diagnostic accuracy and clinicopathological relationships. Brain, 134 (Pt 9) : 2478-2492 (2011).
PubMed
47) Steele JC, Richardson JC, Olszewski J : Progressive supranuclear palsy ; A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol, 10 : 333-359 (1964).
PubMed
48) Takao M, Tsuchiya K, Mimura M, Momoshima S, et al. : Corticobasal degeneration as cause of progressive non-fluent aphasia ; Clinical, radiological and pathological study of an autopsy case. Neuropathology, 26 (6) : 569-578 (2006).
PubMed
49) Tan CF, Piao YS, Kakita A, Yamada M, et al. : Frontotemporal dementia with co-occurrence of astrocytic plaques and tufted astrocytes, and severe degeneration of the cerebral white matter ; A variant of corticobasal degeneration? Acta Neuropathol, 109 (3) : 329-338 (2005).
PubMed
50) Tatsumi S, Mimuro M, Iwasaki Y, Takahashi R, et al. : Argyrophilic grains are reliable disease-specific features of corticobasal degeneration. J Neuropathol Exp Neurol, 73 (1) : 30-38 (2014).
PubMed
51) Tsuboi Y, Josephs KA, Boeve BF, Litvan I, et al. : Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome. Mov Disord, 20 (8) : 982-988 (2005).
PubMed
52) Tsuboi Y : Neuropathology of familial tauopathy. Neuropathology, 26 (5) : 471-474 (2006).
PubMed
53) Tsuchiya K, Ikeda K, Uchihara T, Oda T, et al. : Distribution of cerebral cortical lesions in corticobasal degeneration ; A clinicopathological study of five autopsy cases in Japan. Acta Neuropathol, 94 (5) : 416-424 (1997).
PubMed
54) Tsuchiya K, Murayama S, Mitani K, Oda T, et al. : Constant and severe involvement of Betz cells in corticobasal degeneration is not consistent with pyramidal signs ; A clinicopathological study of ten autopsy cases. Acta Neuropathol, 109 (4) : 353-366 (2005).
 
55) Uchikado H, DelleDonne A, Ahmed Z, Dickson DW : Lewy bodies in progressive supranuclear palsy represent an independent disease process. J Neuropathol Exp Neurol, 65 (4) : 387-395 (2006).
PubMed
56) Verny M, Jellinger KA, Hauw JJ, Bancher C, et al. : Progressive supranuclear palsy ; A clinicopathological study of 21 cases. Acta Neuropathol, 91 (4) : 427-431 (1996).
PubMed
57) Verny M, Duyckaerts C, Agid Y, Hauw JJ : The significance of cortical pathology in progressive supranuclear palsy ; Clinico-pathological data in 10 cases. Brain, 119 (Pt 4) : 1123-1136 (1996).
 
58) Wadia PM, Lang AE : The many faces of corticobasal degeneration. Parkinsonism Relat Disord, 13〔Suppl. 3〕 : S336-S340 (2007).
 
59) Whitwell JL, Jack CR Jr, Parisi JE, Knopman DS, et al. : Rates of cerebral atrophy differ in different degenerative pathologies. Brain, 130 (Pt 4) : 1148-1158 (2007).
 
60) Whitwell JL, Jack CR Jr, Parisi JE, Gunter JL, et al. : Midbrain atrophy is not a biomarker of progressive supranuclear palsy pathology. Eur J Neurol, 20 (10) : 1417-1422 (2013).
PubMed
61) Williams DR, de Silva R, Paviour DC, Pittman A, et al. : Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy ; Richardson's syndrome and PSP-parkinsonism. Brain, 128 (Pt 6) : 1247-1258 (2005).
 
62) Williams DR, Holton JL, Strand K, Revesz T, et al. : Pure akinesia with gait freezing ; A third clinical phenotype of progressive supranuclear palsy. Mov Disord, 22 (15) : 2235-2241 (2007).
PubMed
63) Yokota O, Davidson Y, Bigio EH, Ishizu H, et al. : Phosphorylated TDP-43 pathology and hippocampal sclerosis in progressive supranuclear palsy. Acta Neuropathol, 120 (1) : 55-66 (2010).
PubMed
P.103 掲載の参考文献
1) 安藤烝, 岡庭武, 橘勝也 : Pick病の1剖検例. 神経研究の進歩, 9 (1) : 181-182 (1965).
 
2) Bancher C, Egensperger R, Kosel S, Jellinger K, et al. : Low prevalence of apolipoprotein E epsilon 4 allele in the neurofibrillary tangle predominant form of senile dementia. Acta Neuropathol, 94 (5) : 403-409 (1997).
PubMed
3) Besser LM, Crary JF, Mock C, Kukull WA : Comparison of symptomatic and asymptomatic persons with primary age-related tauopathy. Neurology, 89 (16) : 1707-1715 (2017)
PubMed
4) Braak H, Braak E : Argyrophilic grains ; Characteristic pathology of cerebral cortex in cases of adult onset dementia without Alzheimer changes. Neurosci Lett, 76 (1) : 124-127 (1987).
PubMed
5) Braak H, Braak E : Cortical and subcortical argyrophilic grains characterize a disease associated with adult onset dementia. Neuropathol Appl Neurobiol, 15 (1) : 13-26 (1989).
PubMed
6) Braak H, Braak E : Argyrophilic grain disease ; Frequency of occurrence in different age categories and neuropathological diagnostic criteria. J Neural Transm (Vienna), 105 (8-9) : 801-819 (1998).
 
7) Crary JF, Trojanowski JQ, Schneider JA, Abisambra JF, et al. : Primary age-related tauopathy (PART) ; A common pathology associated with human aging. Acta Neuropathol, 128 (6) : 755-766 (2014).
 
8) Ding ZT, Wang Y, Jiang YP, Yoshida M, et al. : Argyrophilic grain disease ; Frequency and neuropathology in centenarians. Acta Neuropathol, 111 (4) : 320-328 (2006).
PubMed
9) Ferrer I, Santpere G, van Leeuwen FW : Argyrophilic grain disease. Brain, 131 (Pt 6) : 1416-1432 (2008).
 
10) Fujita D, Terada S, Ishizu H, Yokota O, et al. : Immunohistochemical examination on intracranial calcification in neurodegenerative diseases. Acta Neuropathol, 105 (3) : 259-264 (2003).
PubMed
11) Gil MJ, Serrano S, Manzano MS, Cuadrado ML, et al. : Argyrophilic grain disease presenting as behavioral frontotemporal dementia. Clin Neuropathol, 38 (1) : 8-13 (2019).
PubMed
12) Grinberg LT, Heinsen H : Argyrophilic grain disease ; An update about a frequent cause of dementia. Dement Neuropsychol, 3 (1) : 2-7 (2009).
PubMed
13) Hishikawa N, Hashizume Y, Ujihira N, Okada Y, et al. : Alpha-synuclein-positive structures in association with diffuse neurofibrillary tangles with calcification. Neuropathol Appl Neurobiol, 29 (3) : 280-287 (2003).
PubMed
14) Habuchi C, Iritani S, Sekiguchi H, Torii Y, et al. : Clinicopathological study of diffuse neurofibrillary tangles with calcification ; With special reference to TDP-43 proteinopathy and alpha-synucleinopathy. J Neurol Sci, 301 (1-2) : 77-85 (2011).
 
15) Haraguchi T, Ishizu H, Kawai K, Tanabe Y, et al. : Diffuse neurofibrillary tangles with calcification (a form of dementia) ; X-ray spectrometric evidence of lead accumulation in calcified regions. Neuroreport, 12 (6) : 1257-1260 (2001).
PubMed
16) Haraguchi T, Ishizu H, Takehisa Y, Kawai K, et al. : Lead content of brain tissue in diffuse neurofibrillary tangles with calcification (DNTC) ; The possibility of lead neurotoxicity. Neuroreport, 12 (18) : 3887-3890 (2001).
PubMed
17) Honda H, Sasaki K, Hamasaki H, Shijo M, et al. : Trends in autopsy-verified dementia prevalence over 29 years of the Hisayama study. Neuropathology, 36 (4) : 383-387 (2016).
PubMed
18) Ikeda C, Yokota O, Nagao S, Ishizu H, et al. : Corticobasal degeneration initially developing motor versus non-motor symptoms ; A comparative clinicopathological study. PSYCHOGERIATRICS, 14 (3) : 152-164 (2014).
PubMed
19) Ikeda C, Yokota O, Nagao S, Ishizu H, et al. : The Relationship Between Development of Neuronal and Astrocytic Tau Pathologies in Subcortical Nuclei and Progression of Argyrophilic Grain Disease. Brain Pathol, 26 (4) : 488-505 (2016).
PubMed
20) 池田研二 : 精神医学と神経病理学の観点から. 老年精神医学雑誌, 19 (増刊-I) : 28-32 (2008).
 
21) Ikeda K, Akiyama H, Arai T, Sahara N, et al. : A subset of senile dementia with high incidence of the apolipoprotein E epsilon2 allele. Ann Neurol, 41 (5) : 693-695 (1997).
PubMed
22) 石原良子, 入谷修司, 水野裕, 柴山漠人ほか : 石灰沈着を伴うびまん性神経原線維変化病の脳内における金属元素の検討. Neuropathology, 25〔Suppl.〕 : 126 (2005).
 
23) Itoh, Yamada M, Yoshida R, Suematsu N, et al. : Dementia characterized by abundant neurofibril lary tangles and scarce senile plaques ; A quantitative pathological study. Eur Neurol, 36 (2) : 94-97 (1996).
 
24) Iwasaki Y, Deguchi A, Mori K, Ito M, et al. : An autopsy case of a centenarian with the pathology of senile dementia of the neurofibrillary tangle type. PSYCHOGERIATRICS, 17 (2) : 126-129 (2017).
PubMed
25) Janocko NJ, Brodersen KA, Soto-Ortolaza AI, Ross OA, et al. : Neuropathologically defined subtypes of Alzheimer's disease differ significantly from neurofibrillary tangle-predominant dementia. Acta Neuropathol, 124 (5) : 681-692 (2012).
PubMed
26) Jellinger KA, Bancher C : Senile dementia with tangles (tangle predominant form of senile dementia). Brain Pathol, 8 (2) : 367-376 (1998).
PubMed
27) Jellinger KA, Attems J : Neurofibrillary tangle-predominant dementia ; Comparison with classical Alzheimer disease. Acta Neuropathol, 113 (2) : 107-117 (2007).
PubMed
28) Josephs KA, Murray ME, Tosakulwong N, Whitwell JL, et al. : Tau aggregation influences cognition and hippocampal atrophy in the absence of beta-amyloid ; A clinico-imaging-pathological study of primary age-related tauopathy (PART). Acta Neuropathol, 133 (5) : 705-715 (2017).
PubMed
29) 河上緒, 新井哲明, 秋山治彦 : tangle-predominant dementia (神経原線維変化型老年期認知症) の臨床病理学的特徴. 老年精神医学雑誌, 27 (1) : 75-80 (2016).
Medical*Online
30) Kawakami I, Hasegawa M, Arai T, Ikeda K, et al. : Tau accumulation in the nucleus accumbens in tangle-predominant dementia. Acta Neuropathol Commun, 2 : 40 (2014).
PubMed
31) 小阪憲司, 柴山漠人, 小林宏, 星野干城ほか : 分類困難な初老期痴呆症の1 剖検例. 精神経誌, 75 (1) : 18-35 (1973).
 
32) 小阪憲司 : アルツハイマー病, ピック病, Fahr病の特徴を有する初老期痴呆症 ; 「石灰沈着を伴う瀰漫性皮質性神経原線維変化病」の提唱. 老年精神医学雑誌, 3 (7) : 743-750 (1992).
 
33) Kosaka K : Diffuse neurofibrillary tangles with calcification ; A new presenile dementia. J Neurol Neurosurg Psychiatry, 57 (5) : 594-596 (1994).
PubMed
34) Kouri N, Murray ME, Hassan A, Rademakers R, et al. : Neuropathological features of corticobasal degeneration presenting as corticobasal syndrome or Richardson syndrome. Brain, 134 (Pt 11) : 3264-3275 (2011).
PubMed
35) Martinez-Lage P, Munoz DG : Prevalence and disease associations of argyrophilic grains of Braak. J Neuropathol Exp Neurol, 56 (2) : 157-164 (1997).
 
36) Matsui Y, Tanizaki Y, Arima H, Yonemoto K, et al. : Incidence and survival of dementia in a general population of Japanese elderly ; The Hisayama study. J Neurol Neurosurg Psychiatry, 80 (4) : 366-370 (2009).
 
37) Miki T, Yokota O, Ishizu H, Kuroda S, et al. : Behavioral variant of frontotemporal dementia ; Fundamental clinical issues associated with prediction of pathological bases. Neuropathology, 36 (4) : 388-404 (2016).
PubMed
38) 村山繁雄, 齊藤祐子 : その他の認知症. タウオパチーによる認知症 ; DG, NFTD, DNTC. 神経内科, 72〔Suppl.6〕 : 404-408 (2010).
 
39) 村山繁雄 : 嗜銀顆粒性認知症. 最新医学, 71 (3月増刊) : 699-706 (2016).
Medical*Online
40) 長尾茂人, 横田修, 池田智香子, 三木知子ほか : 嗜銀顆粒病. 老年精神医学雑誌, 27 (1) : 51-58 (2016).
Medical*Online
41) Nagao S, Yokota O, Ikeda C, Takeda N, et al. : Argyrophilic grain disease as a neurodegenerative substrate in late-onset schizophrenia and delusional disorders. Eur Arch Psychiatry Clin Neurosci, 264 (4) : 317-331 (2014).
PubMed
42) Nishida N, Hata Y, Yoshida K, Kinoshita K : Neuropathologic features of suicide victims who presented with acute poststroke depression ; Significance of association with neurodegenerative disorders. J Neuropathol Exp Neurol, 74 (5) : 401-410 (2015).
PubMed
43) Perry DC, Brown JA, Possin KL, Datta S, et al. : Clinicopathological correlations in behavioural variant frontotemporal dementia. Brain, 140 (12) : 3329-3345 (2017).
PubMed
44) Petersen RC, Parisi JE, Dickson DW, Johnson KA, et al. : Neuropathologic features of amnestic mild cognitive impairment. Arch Neurol, 63 (5) : 665-672 (2006).
PubMed
45) Pham CT, de Silva R, Haik S, Verny M, et al. : Tau-positive grains are constant in centenarians' hippocampus. Neurobiol Aging, 32 (7) : 1296-1303 (2011).
PubMed
46) Rabano A, Rodal I, Cuadros R, Calero M, et al. : Argyrophilic grain pathology as a natural model of tau propagation. J Alzheimers Dis, 40〔Suppl. 1〕 : S123-133 (2014).
 
47) Rodriguez RD, Suemoto CK, Molina M, Nascimento CF, et al. : Argyrophilic Grain Disease ; Demographics, Clinical, and Neuropathological Features From a Large Autopsy Study. J Neuropathol Exp Neurol, 75 (7) : 628-635 (2016).
PubMed
48) 齊藤祐子, 村山繁雄 : 嗜銀顆粒性認知症の鑑別診断. 最新医学, 68 (4) : 820-826 (2013).
Medical*Online
49) 齊藤祐子 : 嗜銀顆粒性認知症の臨床と診断. 老年精神医学雑誌, 27 (増刊-I) : 80-87 (2016).
 
50) Saito Y, Nakahara K, Yamanouchi H, Murayama S : Severe involvement of ambient gyrus in dementia with grains. J Neuropathol Exp Neurol, 61 (9) : 789-796 (2002).
PubMed
51) Saito Y, Ruberu NN, Sawabe M, Arai T, et al. : Staging of argyrophilic grains ; An age-associated tauopathy. J Neuropathol Exp Neurol, 63 (9) : 911-918 (2004).
PubMed
52) Saito Y, Murayama S : Neuropathology of mild cognitive impairment. Neuropathology, 27 (6) : 578-584 (2007).
PubMed
53) Santa-Maria I, Haggiagi A, Liu X, Wasserscheid J, et al. : The MAPT H1 haplotype is associated with tangle-predominant dementia. Acta Neuropathol, 124 (5) : 693-704 (2012).
PubMed
54) Shibayama H, Kobayashi H, Nakagawa M, Yamada K, et al. : Non-Alzheimer non-Pick dementia with Fahr's syndrome. Clin Neuropathol, 11 (5) : 237-250 (1992).
 
55) Shioya A, Saito Y, Arima K, Kakuta Y, et al. : Neurodegenerative changes in patients with clinical history of bipolar disorders. Neuropathology, 35 (3) : 245-253 (2015).
PubMed
56) 田辺康之, 黒田重利 : 石灰沈着を伴うびまん性神経原線維変化病 (DNTC). Dementia Japan, 15 (1) : 8-15 (2001).
 
57) Tanabe Y, Ishizu H, Ishiguro K, Itoh N, et al. : Tau pathology in diffuse neurofibrillary tangles with calcification (DNTC) ; Biochemical and immunohistochemical investigation. Neuroreport, 11 (11) : 2473-2477 (2000).
PubMed
58) Tatsumi S, Mimuro M, Iwasaki Y, Takahashi R, et al. : Argyrophilic grains are reliable disease-specific features of corticobasal degeneration. J Neuropathol Exp Neurol, 73 (1) : 30-38 (2014).
PubMed
59) 寺田整司 : 石灰化を伴うびまん性神経原線維変化病 (DNTC). 老年精神医学雑誌, 27 (1) : 67-74 (2016).
Medical*Online
60) Terada S, Ishizu H, Tanabe Y, Takehisa Y, et al. : Plaque-like structures and arteriosclerotic changes in "diffuse neurofibrillary tangles with calcification" (DNTC). Acta Neuropathol, 102 (6) : 597-603 (2001).
PubMed
61) Togo T, Cookson N, Dickson DW : Argyrophilic grain disease ; Neuropathology, frequency in a dementia brain bank and lack of relationship with apolipoprotein E. Brain Pathol, 12 (1) : 45-52 (2002).
 
62) Togo T, Sahara N, Yen SH, Cookson N, et al. : Argyrophilic grain disease is a sporadic 4-repeat tauopathy. J Neuropathol Exp Neurol, 61 (6) : 547-556 (2002).
PubMed
63) Tolnay M, Spillantini MG, Goedert M, Ulrich J, et al. : Argyrophilic grain disease ; Widespread hyperphosphorylation of tau protein in limbic neurons. Acta Neuropathol, 93 (5) : 477-484 (1997).
PubMed
64) Tolnay M, Clavaguera F : Argyrophilic grain disease ; A late-onset dementia with distinctive features among tauopathies. Neuropathology, 24 (4) : 269-283 (2004).
PubMed
65) Tsuchiya K, Mitani K, Arai T, Yamada S, et al. : Argyrophilic grain disease mimicking temporal Pick's disease ; A clinical, radiological, and pathological study of an autopsy case with a clinical course of 15 years. Acta Neuropathol, 102 (2) : 195-199 (2001).
PubMed
66) Uchihara T : Pretangles and neurofibrillary changes ; Similarities and differences between AD and CBD based on molecular and morphological evolution. Neuropathology, 34 (6) : 571-577 (2014).
PubMed
67) 鵜飼克行, 小阪憲司 : 日本における石灰沈着を伴うびまん性神経原線維変化病 (小阪・柴山病). 精神経誌, 119 (7) : 463-471 (2017).
 
68) Ukai K, Shibayama H, Ishihara R, Ozaki N : Distribution of neurofibrillary tangles in diffuse neurofibrillary tangles with calcification. Psychiatry Clin Neurosci, 63 (5) : 646-651 (2009).
PubMed
69) Ukai K, Kosaka K : Diffuse neurofibrillary tangles with calcification (Kosaka-Shibayama disease) in Japan. Psychiatry Clin Neurosci, 70 (3) : 131-140 (2016).
PubMed
70) Ulrich J, Spillantini MG, Goedert M, Dukas L, et al. : Abundant neurofibrillary tangles without senile plaques in a subset of patients with senile dementia. Neurodegeneration, 1 : 257-284 (1992).
 
71) 山田正仁 : Senile dementia of the neurofibrillary tangle type (SD-NFT) とPrimary age-related tauopathy (PART) の概念をめぐって. Dementia Japan, 30 (1) : 103-111 (2016).
 
72) 山田正仁 : 神経原線維変化型老年期認知症 ; 診断と治療の展望. 老年精神医学雑誌, 27 (増刊-I) : 73-79 (2016).
 
73) 山田正仁 : 神経原線維変化型老年期認知症. BRAIN and NERVE-神経研究の進歩, 70 (5) : 533-541 (2018).
 
74) Yamada M, Itoh Y, Otomo E, Suematsu N, et al. : Dementia of the Alzheimer's type and related dementias in the aged ; DAT subgroups and senile dementia of the neurofibrillary tangle type. Neuropathology, 16 (2) : 89-98 (1996).
 
75) Yamada M, Itoh Y, Sodeyama N, Suematsu N, et al. : Senile dementia of the neurofibrillary tangle type ; A comparison with Alzheimer's disease. Dement Geriatr Cogn Disord, 12 (2) : 117-126 (2001).
PubMed
76) Yamada M : Senile dementia of the neurofibrillary tangle type (tangle-only dementia) ; Neuropathological criteria and clinical guidelines for diagnosis. Neuropathology, 23 (4) : 311-317 (2003).
PubMed
77) 横田修, 長尾茂人, 池田智香子, 三木知子ほか : 嗜銀顆粒病の認知機能障害, 生活障害, 行動・心理症状. 精神医学, 58 (11) : 941-951 (2016).
 
78) Yokota O, Terada S, Ishizu H, Tsuchiya K, et al. : NACP/alpha-synuclein immunoreactivity in diffuse neurofibrillary tangles with calcification (DNTC). Acta Neuropathol, 104 (4) : 333-341 (2002).
PubMed
79) Yokota O, Miki T, Ikeda C, Nagao S, et al. : Neuropathological comorbidity associated with argyrophilic grain disease. Neuropathology, 38 (1) : 82-97 (2018).
PubMed
80) Yoshida K, Hata Y, Kinoshita K, Takashima S, et al. : Incipient progressive supranuclear palsy is more common than expected and may comprise clinicopathological subtypes ; A forensic autopsy series. Acta Neuropathol, 133 (5) : 809-823 (2017).
PubMed
P.116 掲載の参考文献
1) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. The Huntington's Disease Collaborative Research Group. Cell, 72 (6) : 971-983 (1993).
 
2) Albin RL, Reiner A, Anderson KD, Penney JB, et al. : Striatal and nigral neuron subpopulations in rigid Huntington's disease ; Implications for the functional anatomy of chorea and rigidity-akinesia. Ann Neurol, 27 (4) : 357-365 (1990).
 
3) Cummings JL : Behavioral and psychiatric symptoms associated with Huntington's disease. Adv Neurol, 65 : 179-186 (1995).
 
4) Di Maio L, Squitieri F, Napolitano G, Campanella G, et al. : Onset symptoms in 510 patients with Huntington's disease. J Med Genet, 30 (4) : 289-292 (1993).
 
5) DiFiglia M, Sapp E, Chase KO, Davies SW, et al. : Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science, 277 (5334) : 1990-1993 (1997).
PubMed
6) Ellison D, Love S, Chimelli L, Harding BN, et al. : Neuropathology ; A Reference Text of CNS Pathology. 3rd ed., 600-604, Mosby, Maryland Heights, MO (2013).
 
7) Gomez-Tortosa E, MacDonald ME, Friend JC, Taylor SA, et al. : Quantitative neuropathological changes in presymptomatic Huntington's disease. Ann Neurol, 49 (1) : 29-34 (2001).
 
8) 長谷川一子 : Huntington病 ; 疫学, 診断, 治療. 神経治療学, 32 (2) : 124-129 (2015).
Medical*Online
9) 橋詰良夫, 吉田眞理 : ハンチントン病 ; 核内封入体は神経組織の変性を説明できるか. 病理と臨床, 19 (7) : 728-732 (2001).
 
10) Huntington G : On chorea. Med Surg Reporter, 26 : 317-321 (1872).
 
11) 池田研二 : その他の変性疾患の病理と精神症状 ハンチントン病 ; 精神症状とその病理学的背景. 老年精神医学雑誌, 27 (1) : 59-66 (2016).
 
12) 河上緒, 新里和弘, 新井哲明, 東 晋二ほか : 思春期に窃盗やわいせつ行為などの行動異常が出現し, 診断に難渋したハンチントン病の1例. 臨床精神医学, 44 (9) : 1201-1205 (2015).
Medical*Online
13) 呉秀三 : 精神病性体質・舞踏病・殺人 (鑑定例). 神経学雑誌, 17 : 334-348 (1918)
 
14) 呉秀三 : 精神病性体質・舞踏病・殺人 (完結). 神経学雑誌, 17 : 400-410 (1918).
 
15) Loonen AJ, Ivanova SA : New insights into the mechanism of drug-induced dyskinesia. CNS Spectr, 18 (1) : 15-20 (2013).
PubMed
16) Novak MJ, Tabrizi SJ : Huntington's disease ; Clinical presentation and treatment. Int Rev Neurobiol, 98 : 297-323 (2011).
 
17) Orth M, Handley OJ, Schwenke C, Dunnett SB, et al. ; Investigators of the European Huntington's Disease Network : Observing Huntington's Disease ; The European Huntington's Disease Network's REGISTRY. Version 2, PLoS Curr, 2 : RRN1184 (2010).
 
18) Ribai P, Nguyen K, Hahn-Barma V, Gourfinkel-An I, et al. : Psychiatric and cognitive difficulties as indicators of juvenile huntington disease onset in 29 patients. Arch Neurol, 64 (6) : 813-819 (2007).
PubMed
19) Roos RA : Huntington's disease ; A clinical review. Orphanet J Rare Dis, 5 : 40 (2010).
 
20) 上野秀樹, 池田研二 : ハンチントン病. 病理と臨床, 14 (8) : 1003-1007 (1996).
Medical*Online
21) van Duijn E, Kingma EM, van der Mast RC : Psychopathology in verified Huntington's disease gene carriers. J Neuropsychiatry Clin Neurosci, 19 (4) : 441-448 (2007).
 
22) van Duijn E, Craufurd D, Hubers AA, Giltay EJ, et al. : Neuropsychiatric symptoms in a European Huntington's disease cohort (REGISTRY). J Neurol Neurosurg Psychiatry, 85 (12) : 1411-1418 (2014).
 
23) Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, et al. : Neuropathological classification of Huntington's disease. J Neuropathol Exp Neurol, 44 (6) : 559-577 (1985).
 
24) Vonsattel JP, DiFiglia M : Huntington disease. J Neuropathol Exp Neurol, 57 (5) : 369-384 (1998).
PubMed
25) Walker FO : Huntington's disease. Lancet, 369 (9557) : 218-228 (2007).
 
26) 吉益脩夫 : 舞踏病ノ病理. 神経学雑誌, 28 : 217-243 (1927).
 
P.129 掲載の参考文献
1) Brust JC : Ethanol and cognition ; Indirect effects, neurotoxicity and neuroprotection-A review. Int J Environ Res Public Health, 7 (4) : 1540-1557 (2010).
 
2) Cavanagh JB, Kyu MH : Type II Alzheimer change experimentally produced in astrocytes in the rat. J Neurol Sci, 12 (1) : 63-75 (1971).
 
3) Costin BN, Miles MF : Molecular and neurologic responses to chronic alcohol use. Handb Clin Neurol, 125 : 157-171 (2014).
PubMed
4) Courville CB, Myers RO : Effects of extraneous poisons on the nervous system ; II. The alcohols. Bull Los Angel Neuro Soc, 19 (2) : 66-95 (1955).
 
5) Gazdzinski S, Durazzo TC, Meyerhoff DJ : Temporal dynamics and determinants of whole brain tissue volume changes during recovery from alcohol dependence. Drug Alcohol Depend, 78 (3) : 263-273 (2005).
PubMed
6) Hamberger A, Chiang GH, Sandoval E, Cotman CW : Glutamate as a CNS transmitter ; II. Regulation of synthesis in the releasable pool. Brain Res, 168 (3) : 531-541 (1979).
PubMed
7) Harper C : The neuropathology of alcohol-specific brain damage, or does alcohol damage the brain? J Neuropathol Exp Neurol, 57 (2) : 101-110 (1998).
 
8) Harper C, Dixon G, Sheedy D, Garrick T : Neuropathological alterations in alcoholic brains ; Studies arising from the New South Wales Tissue Resource Centre. Prog Neuropsychopharmacol Biol Psychiatry, 27 (6) : 951-961 (2003).
PubMed
9) Harper C, Matsumoto I : Ethanol and brain damage. Curr Opin Pharmacol, 5 (1) : 73-78 (2005).
PubMed
10) Hoffman PL : Glutamate receptors in alcohol withdrawal-induced neurotoxicity. Metab Brain Dis, 10 (1) : 73-79 (1995).
PubMed
11) 池田研二, 牧野裕, 水上勝義, 入谷修司ほか : ペラグラ性chromatolytic neuronal changesの超微構造について. Dementia, 4 (3) : 259-264 (1990).
 
12) 池田研二 : アルコール性脳障害の神経病理 ; 一次性アルコール性認知症は存在するか? 剖検報告. 認知神経科学, 15 (3) : 175-180 (2014).
 
13) 石井惟友, 西原康雄, 鈴木高秋, 菊池昌弘 : Pellagra sine Pelle Agra ; 精神科・神経内科領域の気付かれない疾患. 精神医学, 23 (2) : 143-151 (1981).
 
14) 鹿島晴雄, 加藤元一郎 : アルコール痴呆 ; 神経心理学類型. 日本臨牀, 55 (特別号1) : 311-318 (1997).
 
15) 小阪憲司, 池田研二 : ウェルニッケ・コルサコフ脳症. 星和書店, 東京 (1984).
 
16) Kril JJ, Halliday GM : Brain shrinkage in alcoholics ; A decade on and what have we learned? Prog Neurobiol, 58 (4) : 381-387 (1999).
PubMed
17) Kroenke CD, Rohlfing T, Park B, Sullivan EV, et al. : Monkeys that voluntarily and chronically drink alcohol damage their brains ; A longitudinal MRI study. Neuropsychopharmacology, 39 (4) : 823-830 (2013).
PubMed
18) Lopez M, Olivares JM, Berrios GE : Pellagra encephalopathy in the context of alcoholism ; Review and case report. Alcohol Alcohol, 49 (1) : 38-41 (2014).
PubMed
19) Mechtcheriakov S, Brenneis C, Egger K, Koppelstaetter F, et al. : A widespread distinct pattern of cerebral atrophy in patients with alcohol addiction revealed by voxel-based morphometry. J Neurol Neurosurg Psychiatry, 78 (6) : 610-614 (2007).
PubMed
20) Mehraein P, Rothemund E : Neuromorphologische Grundlagen des amnestischen Syndrom. Arch Psychiatr Nervenkr, 222 (2-3) : 153-176 (1976).
 
21) Nardone R, Taylor AC, Holler Y, Brigo F, et al. : Minimal hepatic encephalopathy ; A review. Neurosci Res, 111 : 1-12 (2016).
PubMed
22) Roberto M, Schweitzer P, Madamba SG, Stouffer DG, et al. : Acute and chronic ethanol alter glutamatergic transmission in rat central amygdala ; An in vitro and in vivo analysis. J Neurosci, 24 (7) : 1594-1603 (2004).
 
23) Parsons OA, Nixon SJ : Neurobehavioral sequelae of alcoholism. Neurol Clin, 11 (1) : 205-218 (1993).
PubMed
24) Pfefferbaum A, Sullivan EV : Disruption of brain white matter microstructure by excessive intracellular and extracellular fluid in alcoholism ; Evidence from diffusion tensor imaging. Neuropsychopharmacology, 30 (2) : 423-432 (2005).
PubMed
25) Vetreno RP, Hall JM, Savage LM : Alcohol-related amnesia and dementia ; Animal models have revealed the contributions of different etiological factors on neuropathology, neurochemical dysfunction and cognitive impairment. Neurobiol Learn Mem, 96 (4) : 596-608 (2011).
PubMed
26) Victor M, Adams RD, Collins GH : The Wernicke-Korsakoff Syndrome. F.A. Davis, Philadelphia, PA (1971).
 
27) Victor M, Adams RD, Collins GH : The Wernicke-Korsakoff Syndrome and Related Neurological Disorders Due to Alcoholism and Malnutrition. F.A. Davis, Philadelphia, PA (1989).
 
P.139 掲載の参考文献
1) Iwasaki Y, Tatsumi S, Mimuro M, Kitamoto T, et al. : Relation between clinical findings and progression of cerebral cortical pathology in MM1-type sporadic Creutzfeldt-Jakob disease ; Proposed staging of cerebral cortical pathology. J Neurol Sci, 341 (1-2) : 97-104 (2014).
 
2) Iwasaki Y : Creutzfeldt-Jakob disease. Neuropathology, 37 (2) : 174-188 (2017).
PubMed
3) 厚生労働科学研究費補助金・難治性疾患克服研究事業 プリオン病及び遅発性ウイルス感染症に関する調査研究班 (主任研究者 : 水澤英洋, 編集責任者 : 黒岩義之) 「プリオン病感染予防ガイドライン (2008年版) 要約」. (2008). Available at : http://prion.umin.jp/guideline/cjd_2008summary.pdf
 
4) 厚生労働科学研究費補助金・難治性疾患等政策研究事業 (難治性疾患政策研究事業) プリオン病及び遅発性ウイルス感染症に関する調査研究班 (研究代表者 : 山田正仁), 厚生労働行政推進調査事業費補助金・難治性疾患等政策研究事業 (難治性疾患政策研究事業) プリオン病のサーベイランスと感染予防に関する調査研究班 (研究代表者 : 水澤英洋) 「プリオン病診療ガイドライン 2017」. (2017). Available at : http://prion.umin.jp/guideline/guideline_2017.pdf
 
5) Parchi P, Giese A, Capellari S, Brown P, et al. : Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol, 46 (2) : 224-233 (1999).
PubMed
P.152 掲載の参考文献
1) Akatsu H, Takahashi M, Matsukawa N, Ishikawa Y, et al. : Subtype analysis of neuropathologically diagnosed patients in a Japanese geriatric hospital. J Neurol Sci, 196 (1-2) : 63-69 (2002).
 
2) Arima K, Yanagawa S, Ito N, Ikeda S : Cerebral arterial pathology of CADASIL and CARASIL (Maeda syndrome). Neuropathology, 23 (4) : 327-334 (2003).
PubMed
3) Fukutake T, Hirayama K : Familial young-adult-onset arteriosclerotic leukoencephalopathy with alopecia and lumbago without arterial hypertension. Eur Neurol, 35 (2) : 69-79 (1995).
 
4) Hara K, Shiga A, Fukutake T, Nozaki H, et al. : Association of HTRA1 mutations and familial ischemic cerebral small-vessel disease. N Engl J Med, 360 (17) : 1729-1739 (2009).
PubMed
5) Hashizume Y, Yoshida M, Suzuki E, Hirayama M : A 65-year-old man with headaches and left homonymous hemianopsia. Neuropathology, 24 (4) : 350-353 (2004).
PubMed
6) 廣畑美枝, 山田正仁 : 脳アミロイドアンギオパチーの疫学と病態. 医学のあゆみ, 229 (5) : 409-414 (2009).
Medical*Online
7) Ito S, Takao M, Fukutake T, Hatsuta H, et al. : Histopathologic Analysis of Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CARASIL) ; A Report of a New Genetically Confirmed Case and Comparison to 2 Previous Cases. J Neuropathol Exp Neurol, 75 (11) : 1020-1030 (2016).
 
8) Jellinger KA, Attems J : Neuropathological evaluation of mixed dementia. J Neurol Sci, 257 (1-2) : 80-87 (2007).
PubMed
9) Joutel A, Corpechot C, Ducros A, Vahedi K, et al. : Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature, 383 (6602) : 707-710 (1996).
PubMed
10) Kalaria R, Ferrer I, Love S : Chapter 2 vascular disease, hypoxia and related conditions. In Greenfield's Neuropathology, 9th ed., ed. by Love S, Budka H, Ironside JW, Perry A, 59-209, CPC press, New York (2015).
 
11) Knudsen KA, Rosand J, Karluk D, Greenberg SM : Clinical diagnosis of cerebral amyloid angiopathy ; Validation of the Boston criteria. Neurology, 56 (4) : 537-539 (2001).
PubMed
12) Maeda S, Nakayama H, Isaka K, Aihara Y, et al. : Familial unusual encephalopathy of Binswanger's type without hypertension. Folia Psychiatr Neurol Jpn, 30 (2) : 165-177 (1976).
 
13) Masuda J, Tanaka K, Ueda K, Omae T : Autopsy study of incidence and distribution of cerebral amyloid angiopathy in Hisayama, Japan. Stroke, 19 (2) : 205-210 (1988).
 
14) Nozaki H, Nishizawa M, Onodera O : Features of cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy. Stroke, 45 (11) : 3447-3453 (2014).
PubMed
15) Nozaki H, Sekine Y, Fukutake T, Nishimoto Y, et al. : Characteristic features and progression of abnormalities on MRI for CARASIL. Neurology, 85 (5) : 459-463 (2015).
PubMed
16) Nozaki H, Kato T, Nihonmatsu M, Saito Y, et al. : Distinct molecular mechanisms of HTRA1 mutants in manifesting heterozygotes with CARASIL. Neurology, 86 (21) : 1964-1974 (2016).
PubMed
17) O'Brien JT, Thomas A : Vascular dementia. Lancet, 386 (10004) : 1698-1706 (2015).
 
18) 小倉礼, 守吉秀行, 中井紀嘉, 西田卓ほか : ε4/ε2 のアポリポ蛋白E遺伝子型を有したAmyloid-β-related cerebral angiitisの1例. 臨床神経学, 55 (8) : 561-566 (2015).
 
19) Oide T, Nakayama H, Yanagawa S, Ito N, et al. : Extensive loss of arterial medial smooth muscle cells and mural extracellular matrix in cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL). Neuropathology, 28 (2) : 132-142 (2008).
 
20) Opherk C, Peters N, Herzog J, Luedtke R, et al. : Long-term prognosis and causes of death in CADASIL ; A retrospective study in 411 patients. Brain, 127 (Pt 11) : 2533-2539 (2004).
 
21) Pantoni L, Sarti C, Alafuzoff I, Jellinger K, et al. : Postmortem examination of vascular lesions in cognitive impairment ; A survey among neuropathological services. Stroke, 37 (4) : 1005-1009 (2006).
PubMed
22) Pohjasvaara T, Mantyla R, Ylikoski R, Kaste M, et al. : Comparison of different clinical criteria (DSM-III, ADDTC, ICD-10, NINDS-AIREN, DSM-IV) for the diagnosis of vascular dementia. National Institute of Neurological Disorders and Stroke-Association Internationale pour la Recherche et I'Enseignement en Neurosciences. Stroke, 31 (12) : 2952-2957 (2000).
 
23) Salvarani C, Hunder GG, Morris JM, Brown RD Jr, et al. : Aβ-related angitis ; Comparison with CAA without inflammation and primary CNS vasculitis. Neurology, 81 (18) : 1596-1603 (2013).
 
24) Scolding NJ, Joseph F, Kirby PA, Mazanti I, et al. : Aβ-related angiitis ; Primary angiitis of the central nervous system associated with cerebral amyloid angiopathy. Brain, 128 (Pt 3) : 500-515 (2005).
 
25) Shibata M, Ohtani R, Ihara M, Tomimoto H : White matter lesions and glial activation in a novel mouse model of chronic cerebral hypoperfusion. Stroke, 35 (11) : 2598-2603 (2004).
 
26) Shibata M, Yamasaki N, Miyakawa T, Kalaria RN, et al. : Selective impairment of working memory in a mouse model of chronic cerebral hypoperfusion. Stroke, 38 (10) : 2826-2832 (2007).
 
27) Thal DR, Ghebremedhin E, Orantes M, Wiestler OD : Vascular pathology in Alzheimer disease ; Correlation of cerebral amyloid angiopathy and arteriosclerosis/lipohyalinosis with cognitive decline. J Neuropathol Exp Neurol, 62 (12) : 1287-1301 (2003).
PubMed
28) Thal DR, Griffin WS, Braak H : Parenchymal and vascular Abeta-deposition and its effects on the degeneration of neurons and cognition in Alzheimer's disease. J Cell Mol Med, 12 (5B) : 1848-1862 (2008).
 
29) Tikka S, Baumann M, Siitonen M, Pasanen P, et al. : CADASIL and CARASIL. Brain Pathol, 24 (5) : 525-544 (2014).
PubMed
30) Yamada M : Cerebral amyloid angiopathy ; An overview. Neuropathology, 20 (1) : 8-22 (2000).
PubMed
31) Yamada M : Risk factors for cerebral amyloid angiopathy in the elderly. Ann N Y Acad Sci, 977 : 37-44 (2002).
PubMed
32) 山田新一, 熱田直樹, 茂木禧昌, 橋詰良夫ほか : 早期のステロイド治療が有効であった中枢神経の肉芽腫性血管炎の1例. 臨床神経学, 43 (8) : 503-506 (2003).
 
33) Yanagawa S, Ito N, Arima K, Ikeda S : Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy. Neurology, 58 (5) : 817-820 (2002).
 
34) Yokoi S, Nakayama H : Chronic progressive leukoencephalopathy with systemic arteriosclerosis in young adults. Clin Neuropathol, 4 (4) : 165-173 (1985).
PubMed
35) 吉田眞理, 三室マヤ, 橋詰良夫, 早川恵理ほか : 脳肉芽腫性血管炎とβアミロイド沈着. 月刊神経内科, 70 (2) : 180-187 (2009).
 
36) Verdura E, Herve D, Scharrer E, Amador Mdel M, et al. : Heterozygous HTRA1 mutations are associated with autosomal dominant cerebral small vessel disease. Brain, 138 (Pt 8) : 2347-2358 (2015)
PubMed
37) Zhang-Nunes SX, Maat-Schieman ML, van Duinen SG, Roos RA, et al. : The cerebral beta-amyloid angiopathies ; Hereditary and sporadic. Brain Pathol, 16 (1) : 30-39 (2006).
PubMed

第III部 認知症外来における神経病理学的アプローチ

P.162 掲載の参考文献
1) Abdelnour C, van Steenoven I, Londos E, Blanc F, et al. : Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia. Mov Disord, 31 (8) : 1203-1208 (2016).
PubMed
2) Auning E, Rongve A, Fladby T, Booij J, et al. : Early and presenting symptoms of dementia with Lewy bodies. Dement Geriatr Cogn Disord, 32 (3) : 202-208 (2011).
PubMed
3) Birkett DP, Desouky A, Han L, Kaufman M : Lewy bodies in psychiatric patients. Int J Geriatr Psychiatry, 7 : 235-240 (1992).
 
4) Boeve BF, Dickson DW, Olson EJ, Shepard JW, et al. : Insights into REM sleep behavior disorder pathophysiology in brainstem-predominant Lewy body disease. Sleep Med, 8 (1) : 60-64 (2007).
PubMed
5) Bousiges O, Cretin B, Lavaux T, Philippi N, et al. : Diagnostic Value of Cerebrospinal Fluid Biomarkers (Phospho-Tau181, total-Tau, Aβ42, and Aβ40) in Prodromal Stage of Alzheimer's Disease and Dementia with Lewy Bodies. J Alzheimer Dis, 51 (4) : 1069-1083 (2016).
 
6) Braak H, Del Tredici K, Rub U, de Vos RA, et al. : Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging, 24 (2) : 197-211 (2003).
PubMed
7) Braak H, Rub U, Jansen Steur EN, Del Tredici K, et al. : Cognitive status correlates with neuropathologic stage in Parkinson disease. Neurology, 64 (8) : 1404-1410 (2005).
PubMed
8) Ferman TJ, Smith GE, Kantarci K, Boeve BF, et al. : Nonamnestic mild cognitive impairment progresses to dementia with Lewy bodies. Neurology, 81 (23) : 2032-2038 (2013).
PubMed
9) Ferman TJ, Aoki N, Crook JE, Murray ME, et al. : The limbic and neocortical contribution of α-synuclein, tau, and amyloid β to disease duration in dementia with Lewy bodies. Alzheimers Dement, 14 (3) : 330-339 (2018).
 
10) Frigerio R, Fujishiro H, Ahn TB, Josephs KA, et al. : Incidental Lewy body disease ; Do some cases represent preclinical dementia with Lewy bodies? Neurobiol Aging, 32 (5) : 857-863 (2011).
PubMed
11) Fujishiro H, Ferman TJ, Boeve BF, Smith GE, et al. : Validation of the neuropathologic criteria of the third consortium for dementia with Lewy bodies for prospectively diagnosed cases. J Neuropathol Exp Neurol, 67 (7) : 649-656 (2008).
 
12) Fujishiro H, Iseki E, Nakamura S, Kasanuki K, et al. : Dementia with Lewy bodies ; Early diagnostic challenges. PSYCHOGERIATRICS, 13 (2) : 128-138 (2013).
PubMed
13) Fujishiro H, Iritani S, Sekiguchi H, Habuchi C, et al. : Hypochondriasis as early manifestation of dementia with Lewy bodies ; An autopsied case report. PSYCHOGERIATRICS, 16 (2) : 139-144 (2016).
PubMed
14) Fujishiro H, Kawakami I, Oshima K, Niizato K, et al. : Delirium prior to dementia as a clinical phenotype of Lewy body disease ; An autopsied case report. Int Psychogeriatr, 29 (4) : 687-689 (2017).
PubMed
15) 藤城弘樹 : レビー小体型認知症の早期診断の現状と課題. Dementia Japan, 31 (3) : 321-332 (2017).
 
16) 藤城弘樹 : 高齢発症うつ病とレビー小体病. 最新醫學, 73 (5) : 710-714 (2018).
 
17) Galvin JE, Duda JE, Kaufer DI, Lippa CF, et al. : Lewy body dementia ; The caregiver experience of clinical care. Parkinsonism Relat Disord, 16 (6) : 388-392 (2010).
PubMed
18) Greffard S, Verny M, Bonnet AM, Beinis JY, et al. : Motor score of the Unified Parkinson Disease Rating Scale as a good predictor of Lewy body-associated neuronal loss in the substantia nigra. Arch Neurol, 63 (4) : 584-588 (2006).
PubMed
19) Halliday GM, McCann H : The progression of pathology in Parkinson's disease. Ann N Y Acad Sci, 1184 : 188-195 (2010).
PubMed
20) Hyman BT, Phelps CH, Beach TG, Bigio EH, et al. : National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimers Dement, 8 (1) : 1-13 (2012).
PubMed
21) 井関栄三 (編) : レビー小体型認知症 ; 臨床と病態. 中外医学社, 東京 (2014).
 
22) Jicha GA, Schmitt FA, Abner E, Nelson PT, et al. : Prodromal clinical manifestations of neuropathologically confirmed Lewy body disease. Neurobiol Aging, 31 (10) : 1805-1813 (2010).
PubMed
23) 小阪憲司, 松下正明, 小柳新策, Mehraein P : "Lewy小体病"の臨床神経病理学的研究. 精神経誌, 82 (5) : 292-311 (1980).
 
24) Kosaka K : Diffuse Lewy body disease in Japan. J Neurol, 237 (3) : 197-204 (1990).
PubMed
25) McKeith I, Taylor JP, Thomas A, Donaghy P, et al. : Revisiting DLB Diagnosis ; A Consideration of Prodromal DLB and of the Diagnostic Overlap With Alzheimer Disease. J Geriatr Psychiatry Neurol, 29 (5) : 249-253 (2016).
PubMed
26) McKeith IG, Boeve BF, Dickson DW, Halliday G, et al. : Diagnosis and management of dementia with Lewy bodies ; Fourth consensus report of the DLB Consortium. Neurology, 89 (1) : 88-100 (2017).
PubMed
27) Nagao S, Yokota O, Ikeda C, Takeda N, et al. : Argyrophilic grain disease as a neurodegenerative substrate in late-onset schizophrenia and delusional disorders. Eur Arch Psychiatry Clin Neurosci, 264 (4) : 317-331 (2014).
PubMed
28) Onofrj M, Bonanni L, Manzoli L, Thomas A : Cohort study on somatoform disorders in Parkinson disease and dementia with Lewy bodies. Neurology, 74 (20) : 1598-1606 (2010).
PubMed
29) Sarro L, Senjem ML, Lundt ES, Przybelski SA, et al. : Amyloid-β deposition and regional grey matter atrophy rates in dementia with Lewy bodies. Brain, 139 (Pt 10) : 2740-2750 (2016).
 
30) Sunwoo MK, Hong JY, Choi J, Park HJ, et al. : α-Synuclein pathology is related to postoperative delirium in patients undergoing gastrectomy. Neurology, 80 (9) : 810-813 (2013).
 
31) 高橋晶, 水上勝義, 朝田隆 : レビー小体型認知症 (DLB) の前駆症状・初期症状. 老年精神医学雑誌, 22 (増刊-I) : 60-64 (2011).
 
32) Tsopelas C, Stewart R, Savva GM, Brayne C, et al. : Neuropathological correlates of late-life depression in older people. Br J Psychiatry, 198 (2) : 109-114 (2011).
PubMed
33) Uchiyama M, Isse K, Tanaka K, Yokota N, et al. : Incidental Lewy body disease in a patient with REM sleep behavior disorder. Neurology, 45 (4) : 709-712 (1995).
 
34) Vardy E, Holt R, Gerhard A, Richardson A, et al. : History of a suspected delirium is more common in dementia with Lewy bodies than Alzheimer's disease ; A retrospective study. Int J Geriatr Psychiatry, 29 (2) : 178-181 (2014).
PubMed
P.169 掲載の参考文献
1) Blessed G : Clinicopathological studies in mental disorder of old age ; The Newcastle studies 1963-1977. In Contemporary Theses in Psychiatry, ed. by Davison K, Kerr A, 314-321, Alden, Oxford (1989).
 
2) Bleuler M : Late schizophrenic clinical pictures. Fortschr Neurol Psychiatr, 15 : 259-290 (1943).
 
3) Bozikas VP, Kovari E, Bouras C, Karavatos A : Neurofibrillary tangles in elderly patients with late onset schizophrenia. Neurosci Lett, 324 (2) : 109-112 (2002).
PubMed
4) Casanova MF, Stevens JR, Brown R, Royston C, et al. : Disentangling the pathology of schizophrenia and paraphrenia. Acta Neuropathol, 103 (4) : 313-320 (2002).
PubMed
5) Casanova MF : Preservation of hippocampal pyramidal cells in paraphrenia. Schizophr Res, 62 (1-2) : 141-146 (2003).
 
6) Casanova MF : The pathology of paraphrenia. Curr Psychiatry Rep, 12 (3) : 196-201 (2010).
PubMed
7) Crary JF, Trojanowski JQ, Schneider JA, Abisambra JF, et al. : Primary age-related tauopathy (PART) ; A common pathology associated with human aging. Acta Neuropathol, 128 (6) : 755-766 (2014).
 
8) Howard R, Rabins PV, Seeman MV, Jeste DV : Late-onset schizophrenia and very-late-onset schizophrenia-like psychosis ; An international consensus. The International Late-Onset Schizophrenia Group. Am J Psychiatry, 157 (2) : 172-178 (2000).
PubMed
9) 池田研二 : 老年期の幻覚妄想と脳病変. (松下正明編) 新世紀の精神科治療・第3巻 ; 老年期の幻覚妄想-老年期精神科疾患の治療論, 90-128, 中山書店, 東京 (2005).
 
10) Jellinger KA, Attems J : Neurofibrillary tangle-predominant dementia ; Comparison with classical Alzheimer disease. Acta Neuropathol, 113 (2) : 107-117 (2007).
PubMed
11) Josephs KA, Murray ME, Tosakulwong N, Whitwell JL, et al. : Tau aggregation influences cognition and hippocampal atrophy in the absence of beta-amyloid ; A clinico-imaging-pathological study of primary age-related tauopathy (PART). Acta Neuropathol, 133 (5) : 705-715 (2017).
PubMed
12) Kawakami I, Hasegawa M, Arai T, Ikeda K, et al. : Tau accumulation in the nucleus accumbens in tangle-predominant dementia. Acta Neuropathol Commun, 2 : 40 (2014).
PubMed
13) 河上緒, 新井哲明, 秋山治彦 : tangle-predominant dementia (神経原線維変化型老年期認知症) の臨床病理学的特徴. 老年精神医学雑誌, 27 (1) : 75-80 (2016).
Medical*Online
14) Kay DW : Outcome and cause of death in mental disorders of old age ; A long-term follow-up study of functional and organic psychoses. Acta Psychiatr Scand, 38 : 249-276 (1962).
 
15) Nagao S, Yokota O, Ikeda C, Takeda N, et al. : Argyrophilic grain disease as a neurodegenerative substrate in late-onset schizophrenia and delusional disorders. Eur Arch Psychiatry Clin Neurosci, 264 (4) : 317-331 (2014).
PubMed
16) Roth M, Morrissey JD : Problems in the diagnosis and classification of mental disorders in old age ; With a study of case material. J Ment Sci, 98 (410) : 66-80 (1952).
PubMed
P.179 掲載の参考文献
1) Acosta-Cabronero J, Cardenas-Blanco A, Betts MJ, Butryn M, et al. : The whole-brain pattern of magnetic susceptibility perturbations in Parkinson's disease. Brain, 140 (1) : 118-131 (2017).
PubMed
2) Al-Okaili RN, Krejza J, Woo JH, Wolf RL, et al. : Intraaxial brain masses ; MR imaging-based diagnostic strategy-Initial experience. Radiology, 243 (2) : 539-550 (2007).
PubMed
3) Biswas S, Chandran A, Radon M, Puthuran M, et al. : Accuracy of four-dimensional CT angiography in detection and characterisation of arteriovenous malformations and dural arteriovenous fistulas. Neuroradiol J, 28 (4) : 376-384 (2015).
PubMed
4) Filippi M, Agosta F, Barkhof F, Dubois B, et al. ; European Federation of the Neurologic Societies : EFNS task force ; The use of neuroimaging in the diagnosis of dementia. Eur J Neurol, 19 (12) : e131-140, 1487-1501 (2012).
 
5) Harper L, Barkhof F, Scheltens P, Schott JM, et al. : An algorithmic approach to structural imaging in dementia. J Neurol Neurosurg Psychiatry, 85 (6) : 692-698 (2014).
PubMed
6) Kanda T, Nakai Y, Oba H, Toyoda K, et al. : Gadolinium deposition in the brain. Magn Reson Imaging, 34 (10) : 1346-1350 (2016).
PubMed
7) Kashihara K, Shinya T, Higaki F : Reduction of neuromelanin-positive nigral volume in patients with MSA, PSP and CBD. Intern Med, 50 (16) : 1683-1687 (2011).
PubMed
8) Lin E, Alessio A : What are the basic concepts of temporal, contrast, and spatial resolution in cardiac CT? J Cardiovasc Comput Tomogr, 3 (6) : 403-408 (2009).
PubMed
9) Madokoro Y, Sakurai K, Kato D, Kondo Y, et al. : Utility of T1- and T2-Weighted High-Resolution Vessel Wall Imaging for the Diagnosis and Follow Up of Isolated Posterior Inferior Cerebellar Artery Dissection with Ischemic Stroke ; Report of 4 Cases and Review of the Literature. J Stroke Cerebrovasc Dis, 26 (11) : 2645-2651 (2017).
PubMed
10) Nakajima K, Okuda K, Yoshimura M, Matsuo S, et al. : Multicenter cross-calibration of I-123 metaiodobenzylguanidine heart-to-mediastinum ratios to overcome camera-collimator variations. J Nucl Cardiol, 21 (5) : 970-978 (2014).
PubMed
11) Nam Y, Gho SM, Kim DH, Kim EY, et al. : Imaging of nigrosome 1 in substantia nigra at 3T using multiecho susceptibility map-weighted imaging (SMWI). J Magn Reson Imaging, 46 (2) : 528-536 (2017).
PubMed
12) Ohtsuka C, Sasaki M, Konno K, Kato K, et al. : Differentiation of early-stage parkinsonisms using neuromelanin-sensitive magnetic resonance imaging. Parkinsonism Relat Disord, 20 (7) : 755-760 (2014).
PubMed
13) Raji CA, Lopez OL, Kuller LH, Carmichael OT, et al. : Age, Alzheimer disease, and brain structure. Neurology, 73 (22) : 1899-1905 (2009).
PubMed
14) Sakurai K, Miura T, Sagisaka T, Hattori M, et al. : Evaluation of luminal and vessel wall abnormalities in subacute and other stages of intracranial vertebrobasilar artery dissections using the volume isotropic turbo-spin-echo acquisition (VISTA) sequence ; A preliminary study. J Neuroradiol, 40 (1) : 19-28 (2013).
 
15) Sakurai K, Imabayashi E, Tokumaru AM, Hasebe S, et al. : The feasibility of white matter volume reduction analysis using SPM8 plus DARTEL for the diagnosis of patients with clinically diagnosed corticobasal syndrome and Richardson's syndrome. Neuroimage Clin, 7 : 605-610 (2014).
 
16) Sakurai K, Tokumaru AM, Shimoji K, Murayama S, et al. : Beyond the midbrain atrophy ; Wide spectrum of structural MRI finding in cases of pathologically proven progressive supranuclear palsy. Neuroradiology, 59 (5) : 431-443 (2017).
PubMed
17) Shimizu S, Hirao K, Kanetaka H, Namioka N, et al. : Utility of the combination of DAT SPECT and MIBG myocardial scintigraphy in differentiating dementia with Lewy bodies from Alzheimer's disease. Eur J Nucl Med Mol Imaging, 43 (1) : 184-192 (2016).
PubMed
18) Wang Q, Zhang H, Zhang J, Wu C, et al. : The diagnostic performance of magnetic resonance spectroscopy in differentiating high-from low-grade gliomas ; A systematic review and meta-analysis. Eur Radiol, 26 (8) : 2670-2684 (2016).
PubMed
19) Whitwell JL, Jack CR Jr, Boeve BF, Parisi JE, et al. : Imaging correlates of pathology in corticobasal syndrome. Neurology, 75 (21) : 1879-1887 (2010).
PubMed

書評

最近チェックした商品履歴

Loading...